RecruitingNot ApplicableNCT05361837

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

Efficacy of Single Level Versus Bilevel Serratus Anterior Plane Block With Dexmedetomidine During Breast Cancer Surgery


Sponsor

National Cancer Institute, Egypt

Enrollment

172 participants

Start Date

May 10, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • patients scheduled for modified radical mastectomy,
  • Age 18-65 years,
  • ASA I-II

Exclusion Criteria4

  • patient refusal,
  • coagulation defects,
  • abnormal kidney or liver functions,
  • local infection at site of injection.

Interventions

PROCEDURESingle level serratus anterior plane block

Serratus anterior plane block with local anesthetics at the third rib

PROCEDURESingle level serratus anterior plane block with dexmedetomidine

Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib

PROCEDUREBilevel serratus anterior plane block

Serratus anterior plane block with local anesthetics at the third and fifth rib

PROCEDUREBilevel serratus anterior plane block with dexmedetomidine

Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib


Locations(1)

Walaa Y Elsabeeny

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05361837


Related Trials